Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-679-3 | CAS number: 7681-82-5
Endpoint summary
Administrative data
Description of key information
The 24 hours LD50 to rat by oral is 3118 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 3 118 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Since the granular size of the crystals of sodium iodide is evidently bigger than 100 μm, the VP of sodium iodide is low as well; the inhalation is unlikely exposure route for human.
From research (Louk A. R. M. Pechtold et al., 2001), in order to study at the ultrastructural level which part of the skin is associated with percutaneous iodide transport by passive diffusion, the iodide was applied to the frozen skin of human. Then by the transmission electron microscopy (TEM) and X-ray microanalysis (XRMA), the distribution of iodide in each layer of skin after passive diffusion can be well investigated. It concluded that the iodide can penetrate into stratum corneum (SC), but little can enter viable epidermis. Based on this the absorption of iodide by dermal route is also negligible. Therefore the key value of acute toxicity is only available by oral route.
The most relevant study on vertebrates by oral route is a company study (A. Hausner, G. Weise, and A. Hofmann, 1980). In the test the effects of iodide were studied in male and female Wistar rats. 10 male and 10 female in each dose and control groups were administrated with potassium iodide for 14 days at dose of 0 (control), 2000, 2500, 2800 3200, 3600, and 4000 mg/kg body weight mg/kg bw respectively. The key value of LD50 was calculated by Probit-analysis (Fink und Hund 1965).
It shows the 24 hour and 7-14 days of LD50 to rats (male/female) was respectively 3118 and 2779 mg/kg bw under test conditions.
Therefore the key value which is used in the hazard classification and chemical safety assessment is 3118 mg/kg bw.
Justification for classification or non-classification
The LD50 oral is 3118 mg/kg bw, which is definitely above 2000 (mg/kg bodyweight) so the iodide should not be classified under any categories of acute toxicity in the Regulation (EC) No. 1272/2008, and the Directive 67/548/EEC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
